40 results
Page 2 of 2
S-1
6gp0ndvyxq abo
12 Nov 21
IPO registration
5:03pm
10-Q
3rv9rfc2qe z0
14 May 21
Quarterly report
4:31pm
10-K
781rktdt5c kb50vj
31 Mar 21
Annual report
4:30pm
8-K
okog12n6094rrno7 arp
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
boemy3aq830zffq4
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
8-K/A
EX-10.1
1x1sq
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K/A
EX-99.1
lwj9047
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K/A
5nb89u2gqa
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-10.1
8j68h56bxvamdv 9l
15 Dec 20
Departure of Directors or Certain Officers
5:14pm
8-K
b8t31lppsj
15 Dec 20
Departure of Directors or Certain Officers
5:14pm
8-K
EX-3.2
n38vq5a5pq zt
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
odrhyk 37u10asxh9
2 Nov 20
Prospectus supplement
12:00am
S-4/A
j1w5iolsbmn ykgiyl
30 Sep 20
Registration of securities issued in business combination transactions (amended)
9:21am
S-4
1hammr 3wf4f
24 Jul 20
Registration of securities issued in business combination transactions
12:00am